Apple has already signed a non-disclosure agreement with Intel and received initial access to the company’s 18AP process design kit.

Stocks have some momentum heading into December, with all three major indexes nabbing fifth-straight daily wins to end the holiday-shortened week.

Coinbase shares rose after ARK Invest made a $16.5 million purchase, signaling renewed confidence in the crypto market.

Silver's price has surged more than $3 and even broken through the $57 level following last night's COMEX closure and precious metals flash crash. 

25Q3 Y/Y earnings are expected to be 14.7%. Excluding the energy sector, the Y/Y earnings estimate is 15.6%.

Digital assets are moving beyond speculative trades and becoming part of the global financial market. And today’s reset clears the path for the next phase of growth.

Doge may face a larger recovery, as we see it forming a bullish flag pattern from a technical and Elliott Wave perspective.

Regional Fed manufacturing and services indexes for November show manufacturing rebound, continued rampant price pressures, and stagnant employment.

Gold holds above $4,000 as markets focus on dovish Fed signals and unresolved Ukraine–Russia tensions.

The Reserve Bank of India is expected to cut rates by 25 bps.

CF Industries operates a portfolio of world-class nitrogen manufacturing complexes strategically located in the U.S. and the U.K., with strong advantages in scale, low-cost natural gas feedstock, and export access.

After opening the day marginally higher, the Indian benchmark gave up on the gain as the session progressed and ended flat with a negative bias.

Google ended its EU antitrust complaint against Microsoft, but the company still faces an active investigation into its cloud licensing practices.

Gold passed above 4175-85 with signs that more advance is still to come.

The EUR/USD price eased as the dollar pulled back after three consecutive days of losses.

Just in time for your Black Friday excitement, we have a COMEX shutdown, gold and silver flash crashes, and a whole lot of confusion out there right now.

Amgen's stock price surged following the FDA's full approval of IMDELLTRA, positioning the company favorably for long-term growth in oncology and signaling increased market confidence.

Brent touched below $63 per barrel on Friday, heading for a fourth consecutive monthly decline – the longest losing streak in over two years.

Stocks declined on the final trading day of the month, even as expectations for a Fed interest rate cut increased, keeping a global equity index poised for its strongest week since June.

Headline inflation remained unchanged in November, providing new ammunition for those at the European Central Bank arguing against further rate cuts.